UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 288

Sortiert nach

G-CSF-primed bone marrow as a source of stem cells for allografting: revisiting the concept

Bone marrow transplantation (Basingstoke), 2015-09, Vol.50 (9), p.1150-1156

2015

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcome of a pediatric-inspired regimen used for adults aged 18-50 years with newly diagnosed acute lymphoblastic leukemia

Leukemia, 2015-03, Vol.29 (3), p.526-534

2015

Link zum Volltext

Verfügbarkeit prüfen

Risk factors for catheter‐related thrombosis (CRT) in cancer patients: a patient‐level data (IPD) meta‐analysis of clinical trials and prospective studies

Journal of thrombosis and haemostasis, 2011-02, Vol.9 (2), p.312-319

2011

Link zum Volltext

Verfügbarkeit prüfen

A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies

Blood, 2002-09, Vol.100 (5), p.1525-1531

2002

Link zum Volltext

Verfügbarkeit prüfen

Treatment outcomes for older patients with relapsed/refractory aggressive lymphoma receiving salvage chemotherapy and autologous stem cell transplantation are similar to younger patients: a subgroup analysis from the phase III CCTG LY.12 trial

Annals of oncology, 2017-03, Vol.28 (3), p.622-627

2017

Link zum Volltext

Verfügbarkeit prüfen

Characteristics predicting outcomes of allogeneic stem-cell transplantation in relapsed acute myelogenous leukemia

Current oncology (Toronto), 2017-04, Vol.24 (2), p.e123-130

2017

Link zum Volltext

Verfügbarkeit prüfen

A prospective cohort study of the feasibility and efficacy of iron reduction by phlebotomy in recipients of hematopoietic SCT

Bone marrow transplantation (Basingstoke), 2015-03, Vol.50 (3), p.457-458

2015

Link zum Volltext

Verfügbarkeit prüfen

Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin’s disease: a phase II study by the National Cancer Institute of Canada Clinical Trials Group

Annals of oncology, 2003-12, Vol.14 (12), p.1762-1767

2003

Link zum Volltext

Verfügbarkeit prüfen

Low molecular weight heparin for the prevention of hepatic veno-occlusive disease (VOD) after hematopoietic stem cell transplantation: a prospective phase II study

Bone marrow transplantation (Basingstoke), 2003-06, Vol.31 (12), p.1143-1149

2003

Link zum Volltext

Verfügbarkeit prüfen

Duration of first remission and hematopoietic cell transplantation-specific comorbidity index but not age predict survival of patients with AML transplanted in CR2: a retrospective multicenter study

Bone marrow transplantation (Basingstoke), 2016-07, Vol.51 (7), p.1019-1021

2016

Link zum Volltext

Verfügbarkeit prüfen

A Canadian consensus on the management of newly diagnosed and relapsed acute promyelocytic leukemia in adults

Current oncology (Toronto), 2014-10, Vol.21 (5), p.234-250

2014

Link zum Volltext

Verfügbarkeit prüfen

Evidence-based guidelines for the use of tyrosine kinase inhibitors in adults with Philadelphia chromosome-positive or BCR-ABL-positive acute lymphoblastic leukemia: a Canadian consensus

Current oncology (Toronto), 2014-04, Vol.21 (2), p.e265-309

2014

Link zum Volltext

Verfügbarkeit prüfen

Non-myeloablative allogeneic hematopoietic transplantation for patients with hematologic malignancies: 9-year single-centre experience

Current oncology (Toronto), 2014-06, Vol.21 (3), p.e434-440

2014

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of reduced-intensity conditioning allo-SCT for Hodgkin's lymphoma: a national review by the Canadian Blood and Marrow Transplant Group

Bone marrow transplantation (Basingstoke), 2010-07, Vol.45 (7), p.1253-1255

2010

Link zum Volltext

Verfügbarkeit prüfen

Central nervous system graft-versus-host disease presenting with granulomatous encephalitis

Bone marrow transplantation (Basingstoke), 2007-07, Vol.40 (2), p.183-184

2007

Link zum Volltext

Verfügbarkeit prüfen

PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews

Systematic reviews, 2021-01, Vol.10 (1), p.39-39, Article 39

2021

Link zum Volltext

Verfügbarkeit prüfen

Arteriovenous fistula formation in a volunteer allogeneic peripheral blood progenitor cell donor

Bone marrow transplantation (Basingstoke), 2007-09, Vol.40 (5), p.501-502

2007

Link zum Volltext

Verfügbarkeit prüfen

Apixaban to Prevent Venous Thromboembolism in Patients with Cancer

The New England journal of medicine, 2019-02, Vol.380 (8), p.711-719

2019

Link zum Volltext

Verfügbarkeit prüfen

Randomized Placebo-Controlled Study of Low-Dose Warfarin for the Prevention of Central Venous Catheter–Associated Thrombosis in Patients With Cancer

Journal of clinical oncology, 2005-06, Vol.23 (18), p.4063-4069

2005

Link zum Volltext

Verfügbarkeit prüfen

Screening for Occult Cancer in Unprovoked Venous Thromboembolism

The New England journal of medicine, 2015-08, Vol.373 (8), p.697-704

2015

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic Peripheral Blood Stem-Cell Compared With Bone Marrow Transplantation in the Management of Hematologic Malignancies: An Individual Patient Data Meta-Analysis of Nine Randomized Trials

Journal of clinical oncology, 2005-08, Vol.23 (22), p.5074-5087

Stem Cell Trialists' Collaborative Group

2005

Link zum Volltext

Verfügbarkeit prüfen

Confusion of drug names signalled

Canadian Medical Association journal (CMAJ), 1995-06, Vol.152 (11), p.1749

Couban, S

1995

Link zum Volltext

Verfügbarkeit prüfen

An unusual presentation of extramedullary plasmacytoma occurring sequentially in the testis, subcutaneous tissue, and heart

American journal of hematology, 2001-07, Vol.67 (3), p.194-196

2001

Link zum Volltext

Verfügbarkeit prüfen

A reassessment of the value of peripheral blood CD34 enumeration prior to autologous peripheral blood collection.(Stem cell donor)(Author abstract)

Bone marrow transplantation (Basingstoke), 2009-03, Vol.43 (S1), p.S297

2009

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic hematopoietic stem cell transplantation for progressive follicular lymphoma

Bone marrow transplantation (Basingstoke), 2002-06, Vol.29 (12), p.973-978

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 288

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(260)
Mit Volltextzugriff
(260)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

G-CSF-primed bone marrow as a source of stem cells for allografting: revisiting the concept

Long-term outcome of a pediatric-inspired regimen used for adults aged 18-50 years with newly diagnosed acute lymphoblastic leukemia

Risk factors for catheter‐related thrombosis (CRT) in cancer patients: a patient‐level data (IPD) meta‐analysis of clinical trials and prospective studies

A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies

Treatment outcomes for older patients with relapsed/refractory aggressive lymphoma receiving salvage chemotherapy and autologous stem cell transplantation are similar to younger patients: a subgroup analysis from the phase III CCTG LY.12 trial

Characteristics predicting outcomes of allogeneic stem-cell transplantation in relapsed acute myelogenous leukemia

A prospective cohort study of the feasibility and efficacy of iron reduction by phlebotomy in recipients of hematopoietic SCT

Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin’s disease: a phase II study by the National Cancer Institute of Canada Clinical Trials Group

Low molecular weight heparin for the prevention of hepatic veno-occlusive disease (VOD) after hematopoietic stem cell transplantation: a prospective phase II study

Duration of first remission and hematopoietic cell transplantation-specific comorbidity index but not age predict survival of patients with AML transplanted in CR2: a retrospective multicenter study

A Canadian consensus on the management of newly diagnosed and relapsed acute promyelocytic leukemia in adults

Evidence-based guidelines for the use of tyrosine kinase inhibitors in adults with Philadelphia chromosome-positive or BCR-ABL-positive acute lymphoblastic leukemia: a Canadian consensus

Non-myeloablative allogeneic hematopoietic transplantation for patients with hematologic malignancies: 9-year single-centre experience

Outcomes of reduced-intensity conditioning allo-SCT for Hodgkin's lymphoma: a national review by the Canadian Blood and Marrow Transplant Group

Central nervous system graft-versus-host disease presenting with granulomatous encephalitis

PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews

Arteriovenous fistula formation in a volunteer allogeneic peripheral blood progenitor cell donor

Apixaban to Prevent Venous Thromboembolism in Patients with Cancer

Randomized Placebo-Controlled Study of Low-Dose Warfarin for the Prevention of Central Venous Catheter–Associated Thrombosis in Patients With Cancer

Screening for Occult Cancer in Unprovoked Venous Thromboembolism

Allogeneic Peripheral Blood Stem-Cell Compared With Bone Marrow Transplantation in the Management of Hematologic Malignancies: An Individual Patient Data Meta-Analysis of Nine Randomized Trials

Confusion of drug names signalled

An unusual presentation of extramedullary plasmacytoma occurring sequentially in the testis, subcutaneous tissue, and heart

A reassessment of the value of peripheral blood CD34 enumeration prior to autologous peripheral blood collection.(Stem cell donor)(Author abstract)

Allogeneic hematopoietic stem cell transplantation for progressive follicular lymphoma

Suchergebnisse filtern